company background image
LABS

MediPharm Labs TSX:LABS Stock Report

Last Price

CA$0.08

Market Cap

CA$22.6m

7D

-5.9%

1Y

-57.9%

Updated

07 Dec, 2022

Data

Company Financials +
LABS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth1/6
Past Performance0/6
Financial Health5/6
Dividends0/6

LABS Stock Overview

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally.

MediPharm Labs Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for MediPharm Labs
Historical stock prices
Current Share PriceCA$0.08
52 Week HighCA$0.23
52 Week LowCA$0.06
Beta1.04
1 Month Change14.29%
3 Month Change6.67%
1 Year Change-57.90%
3 Year Change-97.65%
5 Year Changen/a
Change since IPO-96.36%

Recent News & Updates

Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Recent updates

Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Aug 20
Time To Worry? Analysts Just Downgraded Their MediPharm Labs Corp. (TSE:LABS) Outlook

Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

May 21
Some Analysts Just Cut Their MediPharm Labs Corp. (TSE:LABS) Estimates

Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Apr 06
Things Look Grim For MediPharm Labs Corp. (TSE:LABS) After Today's Downgrade

Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Mar 07
Is MediPharm Labs (TSE:LABS) Using Too Much Debt?

Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Aug 18
Does MediPharm Labs (TSE:LABS) Have A Healthy Balance Sheet?

Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

May 23
Some MediPharm Labs Corp. (TSE:LABS) Analysts Just Made A Major Cut To Next Year's Estimates

Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last Year

Jan 11
Reflecting on MediPharm Labs' (TSE:LABS) Share Price Returns Over The Last Year

Shareholder Returns

LABSCA PharmaceuticalsCA Market
7D-5.9%-4.7%-2.4%
1Y-57.9%-53.2%-3.2%

Return vs Industry: LABS underperformed the Canadian Pharmaceuticals industry which returned -46.8% over the past year.

Return vs Market: LABS underperformed the Canadian Market which returned -3.4% over the past year.

Price Volatility

Is LABS's price volatile compared to industry and market?
LABS volatility
LABS Average Weekly Movement13.6%
Pharmaceuticals Industry Average Movement14.6%
Market Average Movement9.9%
10% most volatile stocks in CA Market18.4%
10% least volatile stocks in CA Market4.1%

Stable Share Price: LABS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: LABS's weekly volatility (14%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2015190David Pidduckhttps://www.medipharmlabs.com

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services.

MediPharm Labs Corp. Fundamentals Summary

How do MediPharm Labs's earnings and revenue compare to its market cap?
LABS fundamental statistics
Market CapCA$22.57m
Earnings (TTM)-CA$46.14m
Revenue (TTM)CA$22.24m

1.0x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LABS income statement (TTM)
RevenueCA$22.24m
Cost of RevenueCA$27.79m
Gross Profit-CA$5.54m
Other ExpensesCA$40.60m
Earnings-CA$46.14m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.16
Gross Margin-24.91%
Net Profit Margin-207.43%
Debt/Equity Ratio1.7%

How did LABS perform over the long term?

See historical performance and comparison